Inventia Healthcare Limited Nitrofurantoin Export Data — India (DGFT 2022–2026)

Name: Inventia Healthcare Limited Nitrofurantoin Export Records India — #3 Exporter, 12 Shipments, $600.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Nitrofurantoin

India Pharmaceutical Trade Intelligence

$34.2M199 Suppliers92 CountriesHS 30049099

ExportsIndia → UNITED STATES65.4%India → ECUADOR12.2%

ImportsUNITED STATES → India$76.6K UNITED KINGDOM → India$62.1K

#1 Supplier: MANKIND PHARMA #1 Buyer: LIFESTAR PHARMA

Inventia Healthcare Limited — Nitrofurantoin Exporter #3 | $600.0K Trade Value | TransData Nexus | TransData Nexus

Inventia Healthcare Limited — Nitrofurantoin Exporter Profile

Indian Pharmaceutical Exporter · #3 for Nitrofurantoin · $600.0K export value · DGFT Verified

Inventia Healthcare Limited is the #3 Indian exporter of Nitrofurantoin with $600.0K in export value and 12 verified shipments. Inventia Healthcare Limited holds a 1.8% market share in Nitrofurantoin exports across 1 countries. The company exports 11 pharmaceutical products worth $36.5M across 6 therapeutic categories.

Inventia Healthcare Limited — Nitrofurantoin Export Profile: Buyers & Destinations

Inventia Healthcare Limited Nitrofurantoin export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Nitrofurantoin?

Country	Value	Shipments	Share
UNITED STATES	$15.7M	313	68.8%
UNITED KINGDOM	$1.3M	71	5.8%
AUSTRALIA	$1.2M	24	5.3%
SWEDEN	$1.2M	26

Who Are the Top Buyers of Nitrofurantoin from India?

Buyer	Country	Value	Orders
LIFESTAR PHARMA LLC	UNITED STATES	$8.8M	181
RECIPHARM UPPSALA AB KNIVSTA	SWEDEN	$993.6K	22
AMERICAN HEALTH PACKAGING	UNITED STATES	$950.0K	19
NEOETHICALS CIA LTDA	ECUADOR	$650.0K	13
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$650.0K	13
SUN PHARMACEUTICAL INDUSTRIES INC	UNITED STATES	$646.8K	14
TILLOMED LABORATORIES LTD	UNITED KINGDOM	$646.0K	25
JUBILANT CADISTA PHARMACEUTICALS IN	UNITED STATES	$400.0K	8
SANDOZ INC. C/O EXEL, INC.	UNITED STATES	$250.0K	5
SANDOZ INC C O EXEL INC	UNITED STATES	$250.0K	5

India's Nitrofurantoin is purchased by 317 buyers worldwide. The top buyer is LIFESTAR PHARMA LLC (UNITED STATES), followed by RECIPHARM UPPSALA AB KNIVSTA and AMERICAN HEALTH PACKAGING.

How Does Inventia Healthcare Limited Compare to Nearest Nitrofurantoin Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
7	MANKIND PHARMA LTD	$1.1M	24	1	$44.9K
2	CAPLIN POINT LABORATORIES LIMITED	$950.0K	19	4	$50.0K
3	INVENTIA HEALTHCARE LIMITED ★	$600.0K	12	1	$50.0K
9	MEDREICH LIMITED	$533.3K	21	4	$25.4K
10	AUROBINDO PHARMA LIMITED	$525.4K	12	4	$43.8K

Inventia Healthcare Limited ranks #3 among 199 Indian Nitrofurantoin exporters. Average shipment value of $50.0K compared to the market average of $101.4K. The closest competitors by value are MANKIND PHARMA LTD and CAPLIN POINT LABORATORIES LIMITED.

Which Indian Ports Ship Nitrofurantoin Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	264	14.6%
SAHAR AIR CARGO ACC (INBOM4)	238	13.2%
SAHAR AIR	208	11.5%
DELHI AIR	197	10.9%
NHAVA SHEVA SEA (INNSA1)	128	7.1%
JNPT/ NHAVA SHEVA SEA	93	5.1%
Bombay Air	75	4.1%
Delhi Air	71	3.9%

Geopolitical & Trade Policy Impact on Inventia Healthcare Limited's Nitrofurantoin Exports

Inventia Healthcare's extensive export operations are currently navigating a complex geopolitical landscape that presents both challenges and opportunities. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These logistical challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in supply chain management to mitigate potential delays and cost escalations. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The imposition of tariffs on a broad range of imports, including pharmaceuticals, has raised concerns about cost competitiveness and market access. Companies like Inventia must navigate these policy shifts by exploring alternative markets and enhancing operational efficiencies to maintain their competitive edge. (apnews.com)

Conversely, the European Union's stringent regulatory frameworks, such as the Falsified Medicines Directive, necessitate rigorous compliance measures. While these regulations impose additional operational requirements, they also present an opportunity for companies with robust quality systems to differentiate themselves. Inventia's adherence to international quality standards positions it favorably to meet these regulatory demands and strengthen its presence in the European market.

Inventia Healthcare Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA and the European Medicines Agency intensifying their focus on manufacturing practices and product quality. For Indian exporters, this translates into the necessity for stringent compliance with Good Manufacturing Practices (GMP) and other regulatory standards.

Inventia Healthcare's manufacturing facility in Ambernath and its research and development center in Thane are accredited by the U.S. FDA, U.K. MHRA, and other stringent regulatory authorities. This compliance underscores the company's commitment to maintaining high-quality standards, facilitating access to both emerging and regulated markets. (platinumequity.com)

However, the broader Indian pharmaceutical sector faces challenges related to quality assurance, with instances of regulatory non-compliance affecting the industry's reputation. To mitigate these risks, companies like Inventia must continually invest in quality control systems, employee training, and process improvements to ensure sustained compliance and market trust.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Nitrofurantoin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Inventia Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 92+ countries, 317+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Nitrofurantoin

Nitrofurantoin

Inventia Healthcare Limited — Nitrofurantoin Exporter Profile

Inventia Healthcare Limited — Nitrofurantoin Export Profile: Buyers & Destinations

Where Does India Export Nitrofurantoin?

Who Are the Top Buyers of Nitrofurantoin from India?

What Is India's Total Nitrofurantoin Export Value and How Much Does Inventia Healthcare Limited Contribute?

What Is the Average Shipment Value for Inventia Healthcare Limited's Nitrofurantoin Exports?

How Does Inventia Healthcare Limited Compare to Other Indian Nitrofurantoin Exporters?

Regulatory Requirements: Exporting Nitrofurantoin to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Inventia Healthcare Limited Compare to Nearest Nitrofurantoin Exporters?

Which Indian Ports Ship Nitrofurantoin Exports?

Geopolitical & Trade Policy Impact on Inventia Healthcare Limited's Nitrofurantoin Exports

Inventia Healthcare Limited — Regulatory Compliance & Quality Standards

About Inventia Healthcare Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Nitrofurantoin Export Data from Inventia Healthcare Limited

Nitrofurantoin Stats

Company Overview

Top Products by Inventia Healthcare Limited

Related Analysis

Need Detailed Export Data?

Data Source